HL7 Terminology (THO)
6.0.2 - Publication
This page is part of the HL7 Terminology (v6.0.2: Release) based on FHIR (HL7® FHIR® Standard) v5.0.0. This is the current published version in its permanent home (it will always be available at this URL). For a full list of available versions, see the Directory of published versions
Active as of 2021-03-22 |
{
"resourceType" : "CodeSystem",
"id" : "v3-hc-aigc",
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: CodeSystem v3-hc-aigc</b></p><a name=\"v3-hc-aigc\"> </a><a name=\"hcv3-hc-aigc\"> </a><a name=\"v3-hc-aigc-en-US\"> </a><p>This case-insensitive code system <code>http://terminology.hl7.org/CodeSystem/v3-hc-aigc</code> defines codes, but no codes are represented here</p></div>"
},
"url" : "http://terminology.hl7.org/CodeSystem/v3-hc-aigc",
"identifier" : [
{
"system" : "urn:ietf:rfc:3986",
"value" : "urn:oid:2.16.840.1.113883.5.1104"
}
],
"version" : "3.0.1",
"name" : "HcAIGC",
"title" : "Active Ingredient Group Code",
"status" : "active",
"experimental" : false,
"date" : "2021-03-22T00:00:00-04:00",
"publisher" : "Health Canada",
"contact" : [
{
"name" : "Health Canada"
}
],
"description" : "Part of the active ingredient code number starting at position 3 and ending at position 7. \r\n\r\nFurther information about this Code System can be found at https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/drug-product-database/terminology.html",
"caseSensitive" : false,
"content" : "not-present"
}